FDA Panel Backs Pfizer-BioNTech COVID-19 Vaccine For Children Ages 5 To 11

The New York Times (10/26, LaFraniere, Weiland) reports, “An independent committee of experts advising the Food and Drug Administration met on Tuesday and voted to recommend authorizing the Pfizer-BioNTech coronavirus vaccine for children 5 to 11 years ol...